Dioxolanes
AXON MEDCHEM LLC rosiglitazone | 122320-73-4 | 357.4 g/mol | 10MG
rosiglitazone | 122320-73-4 | 357.4 g/mol | 10MG
Medchemexpress LLC Tulisokibart (PRA023), 10 mg, Humanized IgG1-κ Monoclonal Antibody
Tulisokibart (PRA023) is a humanized IgG1-κ monoclonal antibody targeting to TNFSF15/TL1A. Tulisokibart can be used to study a variety of inflammatory/fibrotic diseases, such as Crohn's Disease (CD).
Medchemexpress LLC Ertugliflozin L-pyroglutamic acid | 1210344-83-4 | 99.8% | 566.00 | 5 MG
Ertugliflozin L-pyroglutamic acid is a potent, selective, and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2. It has potential for the treatment of type 2 diabetes mellitus.
- Potent, selective, and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2)
- Potential for the treatment of type 2 diabetes mellitus
- Demonstrates >2000-fold selectivity for SGLT2 inhibition (relative to SGLT1) in vitro
- Reveals a concentration-dependent glucosuria after oral administration to rats
Selleck Chemical LLC Ertugliflozin S5413-25mg
Ertugliflozin (MK-8835 PF-04971729) is a potent and selective sodium-dependent glucose cotransporter 2 inhibitor with IC50 values of 0 877 nM for h-SGLT2 and 1000-fold higher for h-SGLT1
Medchemexpress LLC Erythromycin cyclocarbonate | 55224-05-0 | MFCD01729176 | ≥98.0% | 759.92 | C38H65NO14 | 100 MG
Davercin (erythromycin cyclocarbonate) is a macrolide antibiotic derivative used as a research reagent. It inhibits bacterial protein synthesis and is reported to be active against Gram-positive and some Gram-negative microorganisms. The product is supplied in solid and solution formats with manufacturer guidance for solvent preparation and handling.
- Derivative of erythromycin with antibacterial activity against Gram-positive and some Gram-negative organisms.
- Molecular formula C38H65NO14 and molecular weight about 759.92 g/mol.
- CAS number 55224-05-0 for unambiguous chemical identification.
- Available in solid sizes from 1 mg to 500 mg and as 10 mM solutions in DMSO.
- Soluble in DMSO for preparing stock solutions; limited solubility in water.
- Intended for laboratory research use; follow the safety data sheet and handling instructions.
Medchemexpress LLC Erythromycin cyclocarbonate | 55224-05-0 | MFCD01729176 | >98.0% | 759.92 | C38H65NO14 | 5 MG
Davercin (erythromycin cyclocarbonate) is a semi-synthetic macrolide derivative of erythromycin used as a research reagent. It is reported to inhibit bacterial protein synthesis by binding the 50S ribosomal subunit and shows activity against Gram-positive and some Gram-negative organisms, making it useful for microbiology and antibiotic studies.
- Macrolide antibiotic derivative active against Gram-positive and some Gram-negative bacteria.
- Inhibits protein synthesis through 50S ribosomal binding.
- Suitable as a reference standard or reagent in microbiology and antibiotic research.
- Provided in small quantities for preparing concentrated stock solutions (for example, 1 mg, 5 mg).
- Characterized by CAS 55224-05-0 and molecular formula C38H65NO14.
Medchemexpress LLC Erythromycin cyclocarbonate | 55224-05-0 | MFCD01729176 | >97.0% | 759.92 | C38H65NO14 | 50 MG
Davercin (erythromycin cyclocarbonate) is a macrolide antibiotic derivative of erythromycin used as a research compound. It inhibits bacterial protein synthesis and is active against Gram-positive and some Gram-negative microorganisms. Supplied as a powder, it is intended for in vitro antibacterial studies and medicinal chemistry research.
- Macrolide antibiotic derivative suitable for research use.
- Inhibits bacterial protein synthesis by targeting the 50S ribosomal subunit.
- Active against Gram-positive and some Gram-negative microorganisms.
- Supplied as a powder for flexible formulation and dosing.
- Defined storage conditions to maintain stability.
- Available in small quantities tailored for laboratory studies.